A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839

NCT00212108 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: celecoxib, gefitinib

Sponsor

National University Hospital, Singapore

Collaborators

[object Object]